Matching trials
1,503 results
- A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing…
- A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia: primary endpoint results, effect estimate with confidence…
- A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations: primary endpoint…
- A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®: Complete Statistical AnalysisIndependent statistical analysis of A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01913353).
- A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval,…
- A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1): Complete Statistical AnalysisIndependent statistical analysis of A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive…
- A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01626859).
- A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1): primary endpoint results, effect estimate…
- A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial): primary endpoint results, effect…
- A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson’s Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants:…
- A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic…
- A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic…
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis: primary endpoint results, effect estimate with confidence interval,…
- A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults: primary endpoint results, effect estimate with confidence interval,…
- A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy: primary endpoint…
- A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2…
- A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA): Complete Statistical AnalysisIndependent statistical analysis of A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase III Study to Assess the Lot-to-lot Consistency of GSK’s Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK’s Influenza D-QIV Vaccine in Healthy Non-pregnant Women.: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone…
- A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor: primary endpoint results,…
- A Phase III Trial For Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Trial For Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00191152).
- A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304): Complete Statistical AnalysisIndependent statistical analysis of A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan: Complete Statistical AnalysisIndependent statistical analysis of A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.: Complete Statistical AnalysisIndependent statistical analysis of A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study): Complete Statistical AnalysisIndependent statistical analysis of A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI): Complete Statistical AnalysisIndependent statistical analysis of A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency…
- A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults: Complete Statistical AnalysisIndependent statistical analysis of A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing: Complete Statistical AnalysisIndependent statistical analysis of A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type…
- A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients: Complete Statistical AnalysisIndependent statistical analysis of A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients: primary endpoint results, effect estimate with confidence…
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma: primary endpoint results,…
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787): Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787):…
- A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…